全文获取类型
收费全文 | 1771篇 |
免费 | 100篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 52篇 |
妇产科学 | 41篇 |
基础医学 | 239篇 |
口腔科学 | 23篇 |
临床医学 | 108篇 |
内科学 | 481篇 |
皮肤病学 | 42篇 |
神经病学 | 120篇 |
特种医学 | 41篇 |
外科学 | 212篇 |
综合类 | 10篇 |
预防医学 | 151篇 |
眼科学 | 69篇 |
药学 | 89篇 |
中国医学 | 7篇 |
肿瘤学 | 128篇 |
出版年
2023年 | 7篇 |
2022年 | 14篇 |
2021年 | 45篇 |
2020年 | 20篇 |
2019年 | 52篇 |
2018年 | 46篇 |
2017年 | 43篇 |
2016年 | 35篇 |
2015年 | 34篇 |
2014年 | 55篇 |
2013年 | 84篇 |
2012年 | 103篇 |
2011年 | 105篇 |
2010年 | 59篇 |
2009年 | 60篇 |
2008年 | 90篇 |
2007年 | 98篇 |
2006年 | 94篇 |
2005年 | 98篇 |
2004年 | 91篇 |
2003年 | 98篇 |
2002年 | 74篇 |
2001年 | 77篇 |
2000年 | 91篇 |
1999年 | 67篇 |
1998年 | 18篇 |
1997年 | 13篇 |
1996年 | 9篇 |
1995年 | 6篇 |
1994年 | 9篇 |
1993年 | 5篇 |
1992年 | 22篇 |
1991年 | 18篇 |
1990年 | 10篇 |
1989年 | 14篇 |
1988年 | 19篇 |
1987年 | 14篇 |
1986年 | 18篇 |
1985年 | 11篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1979年 | 4篇 |
1977年 | 4篇 |
1975年 | 2篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1970年 | 3篇 |
1969年 | 3篇 |
1968年 | 2篇 |
1965年 | 2篇 |
排序方式: 共有1873条查询结果,搜索用时 15 毫秒
101.
Victoria E. Rey Caballero Manuel Urbaneja LópezJosé L. García Benítez Dahlia Quijada To Ong 《Progresos de Obstetricia y Ginecología》2008
Cerebral venous sinus thrombosis is uncommon. Pregnancy is a major risk factor for the development of this entity. We report the case of a patient with Job’s syndrome and protein C and S deficiency who developed cerebral venous sinus thrombosis and dural fistula at 36 weeks’ gestation. After heparinization, the treatment of choice, pregnancy termination to eliminate the prothrombotic status and embolization of the dural fistula were required to obtain complete remission of the neurological symptoms. 相似文献
102.
R. García J. M. Hernández M. D. Caballero M. González J. Galende M. C. del Ca?izo L. Vázquez J. F. San Miguel 《British journal of cancer》1993,68(6):1227-1231
The efficacy of currently available treatments for Hodgkin''s disease (HD) has led to a substantial modification in the prognosis of this disease; nevertheless there is still a group of patients that cannot be cured with conventional treatments and who will be candidates for alternative therapy. In the present work we analysed the prognostic influence of the most relevant clinico-biological characteristics of HD in a consecutive series of 137 patients diagnosed and treated in a single institution. Univariate analyses identified six variables with significant prognostic influence, both on achieving complete remission (CR) and overall survival (OS); LDH > 320 U ml-1, age > 45 years, stages IIB, III and IV, extranodal involvement, alkaline phosphatase > 190 UI dl and ESR > 40 mm h. In addition, Hb < 12.5 gr dl-1 and abdominal disease were statistically relevant for CR while a poor performance score (ECOG > or = 2) affected a lower survival. In the multivariate analysis only LDH, age and the clinical stage retained a significant prognostic influence for achieving CR, while the two first factors above, together with performance status were the variables with independent prognostic value with respect to OS. Moreover, only LDH > 320 U ml-1 had prognostic influence in the probability of relapse and disease free survival (DFS), both in the univariate and multivariate analyses. According to the three independent factors obtained in the multivariate analysis for CR (LDH, age and stage) a predictive model was established that allows the stratification of patients into two prognostic groups: one with poor prognosis that includes patients with the three adverse prognostic factors, or two if one of them was elevated LDH, and the other with good prognosis that includes the remaining patients. This model was also able to separate two independent groups of patients with respect to OS and to DFS. In conclusion, the present study shows that LDH is one of the most important prognostic factors in HD. 相似文献
103.
Resto VA Caballero OL Buta MR Westra WH Wu L Westendorf JM Jen J Hieter P Sidransky D 《Cancer research》2000,60(19):5529-5535
Genetic alterations of chromosome 7 are common in human cancer. Furthermore, previous studies have supported the presence of a gene important in a broad range of cancers at 7q22-31.1. There is evidence that supports an oncogenic function for this putative gene, as well as evidence that supports a tumor suppressive role. In this study, we used a cross-species candidate gene approach in combination with physical mapping to identify MPP11 as a candidate for the putative cancer-related activity at 7q22-31.1. We then analyzed primary head and neck squamous cell tumors (HNSCCs) for loss of heterozygosity/allelic imbalance (LOH/AI) at the MPP11 genomic locus. Thirty-eight percent of tumors examined displayed LOH/AI involving the MPP11 genomic locus. Mutation analysis of MPP11 in the latter samples did not identify any inactivating mutations. However, immunohistochemical staining of primary tumor sections and Western blot analysis of HNSCC cell lines revealed a tumor-specific high level of expression of MPP11p. Fluorescence in situ hybridization analysis done on the cell lines identified increased chromosome 7 copy number with a concomitant increase in MPP11 copy number. These results suggest an oncogenic role for MPP11 in HNSCC. 相似文献
104.
Fernández Rodríguez R Porto Golpe I Lema Mougán R Lechuga García R Labella Caballero T 《Acta otorrinolaringologica espanola》1999,50(7):539-542
Involvement of the cervical lymph nodes is one of the commonest forms of extrapulmonary tuberculosis. Given this, we carried out a retrospective study of those cases diagnosed in our health region from 1995-1997, looking at the diagnostic criteria and treatment regimes and comparing our findings with those of other authors. 相似文献
105.
V. Soriano A. Vallejo M. Gutiérrez C. Tuset G. Cilla R. Martínez-Zapico F. Dronda E. Caballero E. Calderón A. Aguilera A. M. Martín J. Llibre J. del Romero R. Ortiz de Lejarazu F. Ulloa J. Eirós J. González-Lahoz 《European journal of epidemiology》1996,12(6):625-629
The human T-lymphotropic virus type II (HTLV-II) has recently been associated with the genesis of some subacute neurological syndromes and, rarely, with atypical T-lymphoid malignancies. The virus is endemic in some Amerindian and African tribes, and among intravenous drug users (IDUs) in North America and Europe. Given that HTLV-II is transmitted by the same routes as other human retroviruses, the screening of antibodies to HTLV-II in blood donors has became a matter of controversy in some countries. Herein, we describe the clinical, epidemiological and virological features of 113 individuals with HTLV-II infection identified in Spain up to September 1995. Most of them (94/113; 83%) were male, and all but seven were natives. Four were African immigrants living in Madrid and 3 had been born in other European countries. All but six subjects were IDUs, and sexual transmission of HTLV-II and transfusion were involved in five and one individual, respectively. Eighty-four percent of the IDUs infected with HTLV-II were co-infected by HIV-1 (93/107). Clinical manifestations potentially linked to HTLV-II were absent, although an IDU male co-infected by HIV-1 and HTLV-II developed a severe non-inflammatory proximal myopathy. In conclusion, HTLV-II infection is present in Spain, mainly among IDUs, with a growing incidence and a current overall prevalence of 2.0 percent.The members of the HTLV Spanish Study Group are listed in the Appendix. 相似文献
106.
Prognostic significance of pathological and biological factors in hepatocellular carcinoma 总被引:3,自引:0,他引:3
IRENE OL NG 《Journal of gastroenterology and hepatology》1998,13(6):666-670
Prognostic factors in hepatocellular carcinoma (HCC) conventionally consist of staging with the tumour node metastasis system and grading by tumour cellular differentiation. There are also other factors useful in prognostication but most of them are clinical. With new discoveries in the pathobiology of cancers and introduction of new medical technology, pathological and biological factors of HCC in relation to prognosis have been studied quite extensively. Morphological features of the tumour, both gross and histological, have been found to be significantly related to tumour recurrence and patient survival. Recently, applications of new antibodies and techniques have enabled studies on cellular proliferation using different antibodies such as those for proliferating cell nuclear antigen and Ki-67 protein. These studies on cellular proliferation, as well as assessment of argyrophilic nucleolar organizing regions, have been shown to provide good prognostic significance. Flow cytometric studies on DNA ploidy and studies on expression of genes including the p53 gene, hormone receptors and others show less unanimous results in their prognostic significance. The influence of gender on survival is also reviewed. In conclusion, pathological and biological factors are useful and help to guide clinicians in the management of patients and in assessment of long-term prognosis. 相似文献
107.
Díez-Campelo M Pérez-Simón JA Ocio EM Castilla C González-Porras JR Sánchez-Guijo FM Vázquez L Caballero MD Cañizo MC San Miguel JF 《Leukemia & lymphoma》2005,46(2):177-183
While in bone marrow allogeneic transplantation the infusion of high doses of progenitor stem cells has a favourable impact on outcome, due to a faster hematopoietic and immune recovery, in the peripheral blood allo-setting the infusion of a high number of CD34 cells increases the risk of extensive chronic graft vs. host disease (cGVHD). This higher incidence of extensive cGVHD has an adverse impact on outcome due to a higher transplant related mortality, specially among patients receiving T-cell depleted allogeneic transplantation with myeloablative conditioning. By contrast, patients undergoing reduced intensity conditioning regimen may benefit from increasing higher CD34 + cell doses, especially those categorized as high risk according to disease status at transplant. Thus, the source of progenitors cells, type of conditioning and GVHD prophylaxis, among other factors, may influence the effect of the progenitor cell dose on outcome after allogeneic transplant. 相似文献
108.
Baiocchi OC Colleoni GW Caballero OL Vettore AL Bulgarelli A Dalbone MA Granato CF Franco MF Pestana JO 《Leukemia & lymphoma》2005,46(4):533-539
The possible correlation among Epstein-Barr virus (EBV) load, interleukin-6 (IL-6) and interleukin-10 (IL-10) levels has become an attractive issue and can provide a useful tool for diagnosis and monitoring of patients at risk for post-transplant lymphoproliferative disease (PTLD) development. At the time of diagnosis of PTLD, 11 patients were prospectively enrolled and 55 nested controls were selected from a 1800 renal transplant cohort. Real-time polymerase chain reaction (PCR) was used to quantify EBV load in peripheral blood mononuclear cells (PBMC). Serum IL-6 and IL-10 levels were determined using an enzyme-linked immunosorbent assay (ELISA). The median EBV load of PTLD cases was 17400 copies/10(6) PBMC, statistically different from controls (P=0.001). The median IL-6 level of PTLD cases was not different from controls (P=0.079). However, median IL-10 levels showed a significant difference in both groups (P < or = 0.001). The receiver-operating characteristic (ROC) curve analysis was applied to estimate the IL-10 cut-off value predictive of PTLD development. We found that 73.5 pg/ml has high sensitivity (1.00) and specificity (0.85). Also, Pearson's analysis showed a strong correlation between EBV load and serum IL-10 concentration (P < or = 0.001). This nested case-control study demonstrates that EBV load at diagnosis of PTLD correlates with IL-10 levels, and that monitoring of IL-10 can provide a less expensive and less time-consuming tool for PTLD diagnosis and close follow-up of patients at risk. Furthermore, we were able to define a cut-off value of IL-10 mostly predictive of PTLD development in this cohort. Our data suggest that serial measurements prior to PTLD development must be carried out to validate our hypothesis. 相似文献
109.
110.
Gonzalez Molina M Alonso A Briones R Fernandez N Caballero A Miranda JM Navarro A Castro MJ Burgos D Cabello M Sola E Escaño A Muñoz J Aranda J De la Fuente A 《Transplantation proceedings》2005,37(3):1443-1445
Diabetic patients with end-stage renal disease have a high mortality rate. A combined kidney-pancreas transplant is associated with greater life expectancy. Pancreas islet transplantation is an alternative involving a lower degree of morbidity. We present two patients, of 41 and 37 years of age, with a long history of diabetes mellitus (C-peptide negative), both with a previous kidney transplant, who had been treated with 22 and 28 U of insulin/d, respectively. Both patients had frequent episodes of unawareness hypoglycemia. Pancreatic islets were infused to a total of 7809 and 19,180 IE/kg, respectively. Basal posttransplant C peptide levels were 2.9 and 1.3 ng/mL. After the implant, one patient required occasional doses of insulin, and the other patient more than 50% reduced dose. After the first implant neither patient had any episodes of unawareness hypoglycemia. HbA1c at 4 months were 6.2% and 6.9%. There were no transplant-related complications. 相似文献